Contract award · SPE2DS22F0020
8508632011!CELLTRION DIATRUST COVID-19
Awarded to CELLTRION USA, INC. · CAGE 8DHW3
Latest reported total obligated
Not reported
Net observed obligations
$37.6M
Observed contract actions
5
Observed period
FY2022–FY2022
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorCELLTRION USA, INC.
CAGE8DHW3
CustomerDefense Logistics Agency
Performance locationJERSEY CITY, NEW JERSEY, UNITED STATES
Procurement details
First observed actionOct 20, 2021
Latest observed actionApr 8, 2022
PSC6640
NAICS325412 · Pharmaceutical Preparation Manufacturing
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
Annual observed obligations
FY2022
$37.6M
Continue exploring
Ask Mimir about SPE2DS22F0020
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.